1887

Journal of General Virology header logo

Volume 86, Issue 3

Genetic variation and dynamics of hepatitis C virus replicons in long-term cell culture Free

Abstract

Hepatitis C virus (HCV) genomic sequences are known to vary widely among HCV strains, but to date there have been few reports on the genetic variations and dynamics of HCV in an experimental system of HCV replication. In this study, a genetic analysis of HCV replicons obtained in long-term culture of two HCV replicon cells (50-1 and 1B-2R1), which were established from two HCV strains, 1B-1 and 1B-2, respectively, was performed. One person cultured 50-1 cells for 18 months, and two people independently cultured 50-1 cells for 12 months. 1B-2R1 cells were also cultured for 12 months. The whole nucleotide sequences of the three independent replicon RNA clones obtained at several time points were determined. It was observed that genetic mutations in both replicons accumulated in a time-dependent manner, and that the mutation rates of both replicons were approximately 3·0×10 base substitutions/site/year. The genetic diversity of both replicons was also enlarged in a time-dependent manner. The colony formation assay by transfection of total RNAs isolated from both replicon cells at different time points into naïve HuH-7 cells revealed that the genetic mutations accumulating with time in both replicons apparently improved colony formation efficiency. Taken together, these results suggest that the HCV replicon system is useful for the analysis of evolutionary dynamics and variations of HCV. Using this replicon cell culture system, it was demonstrated further that neither ribavirin nor its derivative mizoribine accelerated the mutation rate or the increase in the genetic diversity of HCV replicon.

  • Received:
  • Accepted:
  • Published Online:
SGM
Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.80479-0
2005-03-01
2024-04-26
Loading full text...

Full text loading...

/deliver/fulltext/jgv/86/3/vir860645.html?itemId=/content/journal/jgv/10.1099/vir.0.80479-0&mimeType=html&fmt=ahah

References

  1. Alam S. S., Nakamura T., Naganuma A., Nozaki A., Nouso K., Shimomura H., Kato N. 2002; Hepatitis C virus quasispecies in cancerous and noncancerous hepatic lesions: the core protein-encoding region. Acta Med Okayama 56:141–147
     [Google Scholar]
  2. Ali S., Pellerin C., Lamarre D., Kukolj G. 2004; Hepatitis C virus subgenomic replicons in the human embryonic kidney 293 cell line. J Virol 78:491–501 [CrossRef]
     [Google Scholar]
  3. Bartenschlager R. 2002; Hepatitis C virus replicons: potential role for drug development. Nat Rev Drug Discov 1:911–916 [CrossRef]
     [Google Scholar]
  4. Bartenschlager R., Lohmann V. 2000; Replication of hepatitis C virus. J Gen Virol 81:1631–1648
     [Google Scholar]
  5. Blight K. J., Kolykhalov A. A., Rice C. M. 2000; Efficient initiation of HCV RNA replication in cell culture. Science 290:1972–1974 [CrossRef]
     [Google Scholar]
  6. Blight K. J., McKeating J. A., Marcotrigiano J., Rice C. M. 2003; Efficient replication of hepatitis C virus genotype 1a RNAs in cell culture. J Virol 77:3181–3190 [CrossRef]
     [Google Scholar]
  7. Bukh J., Miller R. H., Purcell R. H. 1995; Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis 15:41–63 [CrossRef]
     [Google Scholar]
  8. Choo Q. L., Kuo G., Weiner A. J., Overby L. R., Bradley D. W., Houghton M. 1989; Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359–362 [CrossRef]
     [Google Scholar]
  9. Contreras A. M., Hiasa Y., He W., Terella A., Schmidt E. V., Chung R. T. 2002; Viral RNA mutations are region specific and increased by ribavirin in a full-length hepatitis C virus replication system. J Virol 76:8505–8517 [CrossRef]
     [Google Scholar]
  10. Grakoui A., Wychowski C., Lin C., Feinstone S. M., Rice C. M. 1993; Expression and identification of hepatitis C virus polyprotein cleavage products. J Virol 67:1385–1395
     [Google Scholar]
  11. Hijikata M., Kato N., Ootsuyama Y., Nakagawa M., Shimotohno K. 1991; Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proc Natl Acad Sci U S A 88:5547–5551 [CrossRef]
     [Google Scholar]
  12. Hijikata M., Mizushima H., Tanji Y., Komoda Y., Hirowatari Y., Akagi T., Kato N., Kimura K., Shimotohno K. 1993; Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus. Proc Natl Acad Sci U S A 90:10773–10777 [CrossRef]
     [Google Scholar]
  13. Ikeda M., Yi M., Li K., Lemon S. M. 2002; Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells. J Virol 76:2997–3006 [CrossRef]
     [Google Scholar]
  14. Kato N. 2001; Molecular virology of hepatitis C virus. Acta Med Okayama 55:133–159
     [Google Scholar]
  15. Kato N., Shimotohno K. 2000; Systems to culture hepatitis C virus. Curr Top Microbiol Immunol 242:261–278
     [Google Scholar]
  16. Kato N., Hijikata M., Ootsuyama Y., Nakagawa M., Ohkoshi S., Sugimura T., Shimotohno K. 1990a; Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci U S A 87:9524–9528 [CrossRef]
     [Google Scholar]
  17. Kato N., Hijikata M., Ootsuyama Y., Nakagawa M., Ohkoshi S., Shimotohno K. 1990b; Sequence diversity of hepatitis C viral genomes. Mol Biol Med 7:495–501
     [Google Scholar]
  18. Kato N., Ootsuyama Y., Tanaka T., Nakagawa M., Nakazawa T., Muraiso K., Ohkoshi S., Hijikata M., Shimotohno K. 1992; Marked sequence diversity in the putative envelope proteins of hepatitis C viruses. Virus Res 22:107–123 [CrossRef]
     [Google Scholar]
  19. Kato N., Sekiya H., Ootsuyama Y., Nakazawa T., Hijikata M., Ohkoshi S., Shimotohno K. 1993; Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus. J Virol 67:3923–3930
     [Google Scholar]
  20. Kato N., Ikeda M., Sugiyama K., Mizutani T., Tanaka T., Shimotohno K. 1998; Hepatitis C virus population dynamics in human lymphocytes and hepatocytes infected in vitro. J Gen Virol 79:1859–1869
     [Google Scholar]
  21. Kato T., Date T., Miyamoto M., Furusaka A., Tokushige K., Mizokami M., Wakita T. 2003a; Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. Gastroenterology 125:1808–1817 [CrossRef]
     [Google Scholar]
  22. Kato N., Sugiyama K., Namba K., Dansako H., Nakamura T., Takami M., Naka K., Nozaki A., Shimotohno K. 2003b; Establishment of a hepatitis C virus subgenomic replicon derived from human hepatocytes infected in vitro. Biochem Biophys Res Commun 306:756–766 [CrossRef]
     [Google Scholar]
  23. Kishine H., Sugiyama K., Hijikata M. 7 other authors 2002; Subgenomic replicon derived from a cell line infected with the hepatitis C virus. Biochem Biophys Res Commun 293:993–999 [CrossRef]
     [Google Scholar]
  24. Krieger N., Lohmann V., Bartenschlager R. 2001; Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations. J Virol 75:4614–4624 [CrossRef]
     [Google Scholar]
  25. Kuo G., Choo Q. L., Alter H. J. 17 other authors 1989; An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244:362–364 [CrossRef]
     [Google Scholar]
  26. Lanford R. E., Guerra B., Lee H., Averett D. R., Pfeiffer B., Chavez D., Notvall L., Bigger C. 2003; Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(i)-poly(c), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons. J Virol 77:1092–1104 [CrossRef]
     [Google Scholar]
  27. Lohmann V., Korner F., Koch J., Herian U., Theilmann L., Bartenschlager R. 1999; Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285:110–113 [CrossRef]
     [Google Scholar]
  28. Lohmann V., Korner F., Dobierzewska A., Bartenschlager R. 2001; Mutations in hepatitis C virus RNAs conferring cell culture adaptation. J Virol 75:1437–1449 [CrossRef]
     [Google Scholar]
  29. Lohmann V., Hoffmann S., Herian U., Penin F., Bartenschlager R. 2003; Viral and cellular determinants of hepatitis C virus RNA replication in cell culture. J Virol 77:3007–3019 [CrossRef]
     [Google Scholar]
  30. Major M. E., Mihalik K., Fernandez J., Seidman J., Kleiner D., Kolykhalov A. A., Rice C. M., Feinstone S. M. 1999; Long-term follow-up of chimpanzees inoculated with the first infectious clone for hepatitis C virus. J Virol 73:3317–3325
     [Google Scholar]
  31. Martell M., Esteban J. I., Quer J., Genesca J., Weiner A., Esteban R., Guardia J., Gomez J. 1992; Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol 66:3225–3229
     [Google Scholar]
  32. McHutchison J. G., Gordon S. C., Schiff E. R. 7 other authors 1998; Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med 339:1485–1492 [CrossRef]
     [Google Scholar]
  33. Mizushima H., Hijikata M., Tanji Y., Kimura K., Shimotohno K. 1994; Analysis of N-terminal processing of hepatitis C virus nonstructural protein 2. J Virol 68:2731–2734
     [Google Scholar]
  34. Naganuma A., Nozaki A., Tanaka T., Sugiyama K., Takagi H., Mori M., Shimotohno K., Kato N. 2000; Activation of the interferon-inducible 2′-5′-oligoadenylate synthetase gene by hepatitis C core protein. J Virol 74:8744–8750 [CrossRef]
     [Google Scholar]
  35. Naganuma A., Dansako H., Nakamura T., Nozaki A., Kato N. 2004; Promotion of microsatellite instability by hepatitis C virus core protein in human non-neoplastic hepatocyte cells. Cancer Res 64:1307–1314 [CrossRef]
     [Google Scholar]
  36. Ogata N., Alter H. J., Miller R. H., Purcell R. H. 1991; Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc Natl Acad Sci U S A 88:3392–3396 [CrossRef]
     [Google Scholar]
  37. Ohkoshi S., Kojima H., Tawaraya H. 8 other authors 1990; Prevalence of antibody against non-A, non-B hepatitis virus in Japanese patients with hepatocellular carcinoma. Jpn J Cancer Res 81:550–553 [CrossRef]
     [Google Scholar]
  38. Okamoto H., Kojima M., Okada S. 7 other authors 1992; Genetic drift of hepatitis C virus during an 8·2-year infection in a chimpanzee: variability and stability. Virology 190:894–899 [CrossRef]
     [Google Scholar]
  39. Pflugheber J., Fredericksen B., Sumpter R. Jr, Wang C., Ware F., Sodora D. L., Gale M. Jr 2002; Regulation of PKR and IRF-1 during hepatitis C virus RNA replication. Proc Natl Acad Sci U S A 99:4650–4655 [CrossRef]
     [Google Scholar]
  40. Pietschmann T., Lohmann V., Kaul A., Krieger N., Rinck G., Rutter G., Strand D., Bartenschlager R. 2002; Persistent and transient replication of full-length hepatitis C virus genomes in cell culture. J Virol 76:4008–4021 [CrossRef]
     [Google Scholar]
  41. Saito I., Miyamura T., Ohbayashi A. 10 other authors 1990; Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci U S A 87:6547–6549 [CrossRef]
     [Google Scholar]
  42. Schinkel J., de Jong M. D., Bruning B., van Hoek B., Spaan W. J., Kroes A. C. 2003; The potentiating effect of ribavirin on interferon in the treatment of hepatitis C: lack of evidence for ribavirin-induced viral mutagenesis. Antivir Ther 8:535–540
     [Google Scholar]
  43. Simmonds P. 1995; Variability of hepatitis C virus. Hepatology 21:570–583 [CrossRef]
     [Google Scholar]
  44. Tanabe Y., Sakamoto N., Enomoto N. 9 other authors 2004; Synergistic inhibition of intracellular hepatitis C virus replication by combination of ribavirin and interferon-alpha. J Infect Dis 189:1129–1139 [CrossRef]
     [Google Scholar]
  45. Tanaka T., Kato N., Nakagawa M., Ootsuyama Y., Cho M. J., Nakazawa T., Hijikata M., Ishimura Y., Shimotohno K. 1992; Molecular cloning of hepatitis C virus genome from a single Japanese carrier: sequence variation within the same individual and among infected individuals. Virus Res 23:39–53 [CrossRef]
     [Google Scholar]
  46. Tanaka T., Kato N., Cho M. J., Shimotohno K. 1995; A novel sequence found that at the 3′ terminus of hepatitis C virus genome. Biochem Biophys Res Commun 215:744–749 [CrossRef]
     [Google Scholar]
  47. Tokita H., Okamoto H., Iizuka H., Kishimoto J., Tsuda F., Lesmana L. A., Miyakawa Y., Mayumi M. 1996; Hepatitis C virus variants from Jakarta, Indonesia classifiable into novel genotypes in the second (2e and 2f), tenth (10a) and eleventh (11a) genetic groups. J Gen Virol 77:293–301 [CrossRef]
     [Google Scholar]
  48. Young K. C., Lindsay K. L., Lee K. J., Liu W. C., He J. W., Milstein S. L., Lai M. M. 2003; Identification of a ribavirin-resistant NS5B mutation of hepatitis C virus during ribavirin monotherapy. Hepatology 38:869–878 [CrossRef]
     [Google Scholar]
  49. Zhou S., Liu R., Baroudy B. M., Malcolm B. A., Reyes G. R. 2003; The effect of ribavirin and IMPDH inhibitors on hepatitis C virus subgenomic replicon RNA. Virology 310:333–342 [CrossRef]
     [Google Scholar]
  50. Zhu Q., Guo J. T., Seeger C. 2003; Replication of hepatitis C virus subgenomes in nonhepatic epithelial and mouse hepatoma cells. J Virol 77:9204–9210 [CrossRef]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.80479-0
Loading
Genetic variation and dynamics of hepatitis C virus replicons in long-term cell culture
J. Gen. Virol. 86, 645 (2005); https://doi.org/10.1099/vir.0.80479-0
/content/journal/jgv/10.1099/vir.0.80479-0
/content/journal/jgv/10.1099/vir.0.80479-0
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error